Ullman Comments on FDA’s Handling of New Dietary Ingredients

July 1, 2021 | Compliance Investigations & White Collar

Marc Ullman was quoted in the NutraIngredients-USA article, “FDA lists NDI update among priorities for coming year.”

The article discusses a list of priorities released yesterday by the US Food and Drug Administration (FDA), which included New Dietary Ingredients (NDI) Draft Guidance.

“FDA’s entire handling of NDIs has been absurd,” Ullman said. “It seems to me that what they’ve been saying is that they’ve been working for the past decade to put out a set of rules that they’re not going to bother enforcing.”

Read the full article. 

Share this article:

Related News

Get legal updates and news delivered to your inbox